Skip to main content

Table 1 (abstract P48). Characteristics of Included Studies

From: Sepsis 2018

  

Studies

Patients

Total

 

99

588,883

Study design

Prospective

29

84,947

Retrospective

70

506,258

Population

ED

58

394,346

Any (including ED and ICU)

20

172,466

ICU

10

17,765

Prehospital

5

2,641

Non-ICU

5

1,445

Outpatient

1

220

Case mix

Infection/sepsis

91

563,470

Respiratory tract infection

7

25,272

Urinary tract infection

1

141

Setting

Developed countries

89

572,643

Resource-limited countries

10

16,240

Baseline condition/ comorbidity

Unspecified

90

584,898

Elderly

3

2,043

Malignancy

3

1,277

Cirrhosis

1

259

On hemodialysis

1

220

Hematology cases

1

186

Outcome measures

Hospital mortality

63

361,019

28/ 30 days mortality

35

221,001

Early (48 hours – 7 day) mortality

3

6,164

90 day – 6 months mortality

1

1,784

Any mortality

1

37

ICU admission

24

124,004

Ventilator support

3

33,705

Prolonged ICU stay

9

29,935

Organ dysfunction

4

16,634

Publications type

Full text articles

69

435,553

Conference abstracts

30

153,330

Prediction score

Both SIRS and qSOFA

59

383,290

qSOFA only

39

196,869

SIRS only

1

8,724

Inclusion criteria

Fever

1

519

Infection

54

362,440

Sepsis-2

20

168,165

Sepsis-3

7

2,237

Either sepsis-2 or 3

16

55,041

Positive blood culture

1

481